chr7-21559615-C-T

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_001277115.2(DNAH11):​c.705C>T​(p.Asn235Asn) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.44 in 1,593,732 control chromosomes in the GnomAD database, including 158,726 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.46 ( 16846 hom., cov: 32)
Exomes 𝑓: 0.44 ( 141880 hom. )

Consequence

DNAH11
NM_001277115.2 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 0.401

Publications

18 publications found
Variant links:
Genes affected
DNAH11 (HGNC:2942): (dynein axonemal heavy chain 11) This gene encodes a ciliary outer dynein arm protein and is a member of the dynein heavy chain family. It is a microtubule-dependent motor ATPase and has been reported to be involved in the movement of respiratory cilia. Mutations in this gene have been implicated in causing Kartagener Syndrome (a combination of situs inversus totalis and Primary Ciliary Dyskinesia (PCD), also called Immotile Cilia Syndrome 1 (ICS1)) and male sterility. [provided by RefSeq, Mar 2013]
DNAH11 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 7
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), ClinGen
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.38).
BP6
Variant 7-21559615-C-T is Benign according to our data. Variant chr7-21559615-C-T is described in ClinVar as Benign. ClinVar VariationId is 93693.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.401 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.729 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DNAH11NM_001277115.2 linkc.705C>T p.Asn235Asn synonymous_variant Exon 4 of 82 ENST00000409508.8 NP_001264044.1 Q96DT5Q96NT7H9NAJ8H9NAJ7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DNAH11ENST00000409508.8 linkc.705C>T p.Asn235Asn synonymous_variant Exon 4 of 82 5 NM_001277115.2 ENSP00000475939.1 Q96DT5
DNAH11ENST00000483691.1 linkn.-100C>T upstream_gene_variant 3

Frequencies

GnomAD3 genomes
AF:
0.463
AC:
70261
AN:
151730
Hom.:
16817
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.541
Gnomad AMI
AF:
0.210
Gnomad AMR
AF:
0.385
Gnomad ASJ
AF:
0.392
Gnomad EAS
AF:
0.749
Gnomad SAS
AF:
0.541
Gnomad FIN
AF:
0.386
Gnomad MID
AF:
0.417
Gnomad NFE
AF:
0.425
Gnomad OTH
AF:
0.456
GnomAD2 exomes
AF:
0.447
AC:
105203
AN:
235568
AF XY:
0.450
show subpopulations
Gnomad AFR exome
AF:
0.533
Gnomad AMR exome
AF:
0.321
Gnomad ASJ exome
AF:
0.406
Gnomad EAS exome
AF:
0.746
Gnomad FIN exome
AF:
0.386
Gnomad NFE exome
AF:
0.422
Gnomad OTH exome
AF:
0.414
GnomAD4 exome
AF:
0.438
AC:
631657
AN:
1441884
Hom.:
141880
Cov.:
32
AF XY:
0.440
AC XY:
314957
AN XY:
716552
show subpopulations
African (AFR)
AF:
0.537
AC:
17634
AN:
32846
American (AMR)
AF:
0.335
AC:
14229
AN:
42426
Ashkenazi Jewish (ASJ)
AF:
0.407
AC:
10540
AN:
25872
East Asian (EAS)
AF:
0.699
AC:
27459
AN:
39260
South Asian (SAS)
AF:
0.530
AC:
43502
AN:
82006
European-Finnish (FIN)
AF:
0.393
AC:
20872
AN:
53106
Middle Eastern (MID)
AF:
0.452
AC:
2589
AN:
5732
European-Non Finnish (NFE)
AF:
0.425
AC:
467775
AN:
1100982
Other (OTH)
AF:
0.454
AC:
27057
AN:
59654
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.444
Heterozygous variant carriers
0
15891
31782
47673
63564
79455
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
14450
28900
43350
57800
72250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.463
AC:
70339
AN:
151848
Hom.:
16846
Cov.:
32
AF XY:
0.464
AC XY:
34432
AN XY:
74204
show subpopulations
African (AFR)
AF:
0.542
AC:
22424
AN:
41366
American (AMR)
AF:
0.384
AC:
5863
AN:
15262
Ashkenazi Jewish (ASJ)
AF:
0.392
AC:
1360
AN:
3466
East Asian (EAS)
AF:
0.749
AC:
3874
AN:
5172
South Asian (SAS)
AF:
0.542
AC:
2607
AN:
4814
European-Finnish (FIN)
AF:
0.386
AC:
4067
AN:
10528
Middle Eastern (MID)
AF:
0.424
AC:
123
AN:
290
European-Non Finnish (NFE)
AF:
0.425
AC:
28869
AN:
67936
Other (OTH)
AF:
0.457
AC:
961
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1896
3792
5689
7585
9481
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
650
1300
1950
2600
3250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.425
Hom.:
27479
Bravo
AF:
0.463
Asia WGS
AF:
0.628
AC:
2185
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

May 09, 2013
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 21, 2013
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Asn235Asn in exon 4 of DNAH11: This variant is not expected to have clinical sig nificance because it does not alter an amino acid residue and is not located wit hin the splice consensus sequence. It has been identified in 47.0% (1718/3656) o f African American chromosomes from a broad population by the NHLBI Exome Sequen cing Project (http://evs.gs.washington.edu/EVS; dbSNP rs10950854). -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Primary ciliary dyskinesia Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Primary ciliary dyskinesia 7 Benign:1
Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Nov 10, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.38
CADD
Benign
3.8
DANN
Benign
0.65
PhyloP100
0.40
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10950854; hg19: chr7-21599233; COSMIC: COSV60940505; COSMIC: COSV60940505; API